
CEOs of Church & Dwight (CHD), Eli Lilly (LLY), and Viatris (VTRS) have recently made significant share purchases, signaling confidence despite their stocks' underperformance in 2025. CHD's CEO bought over $500k worth of shares, LLY's CEO acquired shares post-earnings weakness, and VTRS's CEO purchased $220k, with all three stocks down 5-12% year-to-date. While insider buys are not explicit short-term signals due to longer holding periods and strict rules, these transactions are closely monitored by investors as a positive indicator for the companies' long-term outlook.
Recent insider buying activity by the respective CEOs of Church & Dwight (CHD), Eli Lilly (LLY), and Viatris (VTRS) signals strong management conviction despite significant year-to-date underperformance. All three large-cap stocks have lagged the S&P 500 in 2025, with CHD down approximately 10%, LLY down 5%, and VTRS down 12%. The transactions are notable in scale and context: CHD's CEO purchased over $500k in shares, VTRS's CEO acquired roughly $220k worth, and LLY's CEO bought following post-earnings weakness, reversing a trend of insider selling earlier in the year. This pattern of executives "buying the dip" suggests a belief that their companies are fundamentally undervalued at current prices. While not a direct signal for near-term performance due to the long-term investment horizons of insiders, these collective actions are a material, positive indicator for the long-term outlook of each firm.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.60
Ticker Sentiment